Staar Surgical Company (STAA) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Staar Surgical Company (STAA:NASDAQ), powered by AI.

Current Price
$28.92
P/E Ratio
-17.8
Market Cap
1.4B
Sector
Healthcare
What is the Staar Surgical Company stock price forecast?

Staar Surgical Company is currently trading at $28.92. View real-time AI analysis on Alpha Lenz.

What is Staar Surgical Company insider trading activity?

View the latest insider trading data for Staar Surgical Company on Alpha Lenz.

What is Staar Surgical Company's P/E ratio?

Staar Surgical Company's P/E ratio is -17.8.

Staar Surgical Company

NASDAQ · STAA
$28.92+0.55(+1.94%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Staar Surgical Company's future dividend policy...
Alpha Chat Insight

Staar Surgical Company trades at a P/E of -17.8 (undervalued) with modest ROE of -21.7%.

Ask for details

Company Overview

Staar Surgical Company is a prominent medical technology firm, chiefly focused on the development, manufacture, and marketing of implantable lenses for the eye. Its primary product lines include lenses used in refractive surgery, most notably the Implantable Collamer Lens (ICL) designed to treat common vision defects such as myopia and astigmatism. Staar Surgical's innovations address unmet needs in global ophthalmology, particularly impacting sectors involved in vision correction and eye care surgeries. As a leader in its industry, the company plays a critical role in the advancement of visual health, offering alternatives to traditional corrective methods like glasses and contact lenses. Headquartered in California, Staar Surgical's reach extends worldwide, serving ophthalmologists and their patients in many countries. Their pioneering technology is considered a significant contributor to the growing field of advanced eye care solutions, signaling the company's market importance and influence. Through continuous research and development, Staar Surgical strives to provide innovative products that enhance quality of life for individuals with visual impairments.

CEOMr. Stephen C. Farrell CFA
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees1,157

Company Statistics

FY 2025

Profile

$1.43BMarket Cap
$239.44MRevenue
0.00Shares Out
1,157Employees

Margins

76.19%Gross
2.48%EBITDA
-19.19%Operating
-34.36%Pre-Tax
-33.60%Net

Valuation

-17.82P/E
4.16P/B
5.99EV/Sales
221.78EV/EBITDA
-35.79P/FCF

Growth (CAGR)

-5.57%Rev 3Yr
7.93%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-16.74%ROA
-21.70%ROE
-9.56%ROIC

Financial Health

$153.15MCash & Cash Equivalents
$-45.66MNet Debt
31.23%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Staar Surgical Company (ticker: STAA) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 1,157 employees. Market cap is $1.4B.

The current price is $28.92 with a P/E ratio of -17.82x and P/B of 4.16x.

ROE is -21.70% and operating margin is -19.19%. Annual revenue is $239M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Staar Surgical Company (STAA) Stock Forecast 2026 $28.92 — Price, Financials & Analyst Targets | Alpha Lenz